Zarontin: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Zarontin (ethosuximide) is an anticonvulsant drug used to treat absence seizures, also known as petit mal seizures. It has been used successfully in patients who have generalized absence seizures, which typically occur in children between the ages of 4 and 12. This article discusses the uses, dosage, demographic, side effects, interactions, and generic options of Zarontin. Uses of Zarontin Zarontin is specifically indicated for the management of absence (petit mal) seizures in children. It is classified as an antiepileptic drug which reduces the threshold for seizure activity. Dosage of Zarontin The dosage of Zarontin varies depending on the age, weight, and condition of the patient. The typical starting dose is 250 mg/day, which is divided into two doses. The dosage is then gradually increased to achieve maximum effectiveness while minimizing side effects. For children, the usual dosage is 750 mg/day, which is also divided into two doses. For adults, the starting dosage is also 250 mg/day, which is then gradually increased to a maximum dose of 1.5g/day. Demographic Suitability of Zarontin Zarontin is typically prescribed for children between the ages of 4-12 years old, but it can also be prescribed for adults who suffer from absence seizures. The use of Zarontin should be avoided in patients who have a history of hypersensitivity to ethosuximide or succinimides. Side effects of Zarontin Some of the side effects of Zarontin include dizziness, headache, fatigue, gastrointestinal disturbances, and ataxia (lack of muscle coordination). These side effects may occur within the first few days of treatment, but usually subside after a few days. However, patients may experience more serious side effects, such as Stevens-Johnson Syndrome (a severe skin reaction), and blood dyscrasias, which requires prompt medical attention. Interactions of Zarontin Zarontin should not be taken with other anticonvulsants or barbiturates, as they may potentiate the effects of Zarontin. Patients who have a history of diabetes should have their blood sugar levels monitored frequently, as Zarontin can decrease insulin release. Additionally, the use of Zarontin with other CNS (central nervous system) depressants such as alcohol, sedatives, and antihistamines can result in increased drowsiness, so caution should be exercised. Generic Options of Zarontin Zarontin is primarily sold under its generic name, ethosuximide, and is available in form of oral capsules and syrup. The generic name drug is also marketed as Emeside, Petinimid, and Sucess. Conclusion Zarontin is a medication that is primarily used to treat absence seizures in children. The dosage of this medication varies based on individual factors such as age and weight. Patients should be monitored for possible side effects such as dizziness, headache, gastrointestinal disturbances and ataxia. Patients who have a history of hypersensitivity to ethosuximide or succinimides should avoid taking Zarontin. Patients should talk to their doctors about any possible interactions of Zarontin with other medications they are taking. Lastly, it is important to remember that the generic options of Zarontin are available under different names, such as Emeside, Petinimid, and Sucess.